|
MGAT5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.46020000219616E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.79550000037432E-07 |
| Normal-vs-Stage2 |
1.99449999999102E-05 |
| Normal-vs-Stage3 |
3.41989999996795E-06 |
| Normal-vs-Stage4 |
1.357290E-03 |
| Stage1-vs-Stage2 |
4.587800E-01 |
| Stage1-vs-Stage3 |
9.772200E-01 |
| Stage1-vs-Stage4 |
6.382400E-01 |
| Stage2-vs-Stage3 |
5.060800E-01 |
| Stage2-vs-Stage4 |
3.744200E-01 |
| Stage3-vs-Stage4 |
6.613400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.77779999966621E-07 |
| Normal-vs-AfricanAmerican |
8.700400E-02 |
| Normal-vs-Asian |
1.65836000000086E-05 |
| Caucasian-vs-AfricanAmerican |
1.784770E-01 |
| Caucasian-vs-Asian |
3.972200E-01 |
| AfricanAmerican-vs-Asian |
8.189500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.667100039768E-09 |
| Normal-vs-Female |
1.60979999996869E-06 |
| Male-vs-Female |
3.733600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.09069999999034E-05 |
| Normal-vs-Age(41-60Yrs) |
3.37559999952219E-07 |
| Normal-vs-Age(61-80Yrs) |
2.17170000005318E-06 |
| Normal-vs-Age(81-100Yrs) |
1.964180E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.279600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.123000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.619600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.436600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.941400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.958200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.868000E-01 |
| Classical-VS-Follicular |
2.499600E-02 |
| Classical-VS-Other |
7.784000E-02 |
| Classical-VS-Normal |
2.26950000004056E-06 |
| Tall-VS-Follicular |
3.762000E-02 |
| Tall-VS-Other |
7.714000E-02 |
| Tall-VS-Normal |
3.197600E-02 |
| Follicular-VS-Other |
2.742800E-01 |
| Follicular-VS-Normal |
2.33339999544668E-08 |
| Other-VS-Normal |
9.965600E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.69399979891239E-10 |
| Normal-vs-N1 |
1.95449999995656E-06 |
| N0-vs-N1 |
7.701400E-01 |
|
|
